Industry Distribution:

• Pharmaceuticals: approx. 45%
• Biotechnology: approx. 25%
• Medical Devices and Technologies: approx. 20%
• Healthcare Services: approx. 10%

TOP 3 Markets:

• USA: approx. 55%
• Europe: approx. 25%
• Japan: approx. 10%

The iShares Global Healthcare ETF (IXJ) invests in companies from various sectors of the healthcare industry, with the largest share allocated to pharmaceuticals. The USA dominates as the main market, driven by the strong presence of leading healthcare companies and high demand for healthcare services.

Europe and Japan follow as important markets, also making significant contributions to the ETF's revenues. These markets benefit from an aging population and a high demand for innovative healthcare solutions.

iShares Trust - iShares Global Healthcare ETF (ARCA:IXJ) is an exchange-traded fund (ETF) and not a company that produces physical products.

This ETF invests in a variety of companies in the healthcare sector worldwide. Therefore, the ETF itself does not produce products, but holds shares in companies operating in the healthcare industry. The production sites depend on the respective companies in which the ETF invests.

Current Strategy: Diversification and Innovation in Healthcare Sectors
Focus: Biotechnology and Digital Health Solutions

The iShares Global Healthcare ETF (IXJ) pursues a strategy that aims for diversification within the healthcare sector. The fund invests in a variety of companies operating in different areas of the healthcare industry, including pharmaceuticals, biotechnology, and medical technology.

A particular focus is on the integration of digital health solutions and the promotion of innovations in biotechnology. These areas promise high growth potential as they benefit from technological advancements and increasing demand for personalized healthcare solutions.

Additionally, the fund is supported by demographic trends, as an aging population worldwide leads to increased demand for healthcare services. The ETF leverages these trends to achieve long-term stable returns.

Commodities/Materials: Pharmaceutical active ingredients, medical technology components

Countries of origin: China, India, Germany, Switzerland

The iShares Global Healthcare ETF (IXJ) invests in companies from the healthcare sector that are often dependent on pharmaceutical active ingredients and medical technology components. China and India are leading exporters of pharmaceutical active ingredients, while Germany and Switzerland are known for their high-quality medical technology products.

Since the ETF itself does not import commodities but invests in companies that use these materials, the mentioned countries are important suppliers for the companies included in the ETF.

Current fund assets: $5.2 billion USD (2025)
Annual return: 7.8% (2024)
Expense ratio: 0.43% (2025)

The iShares Global Healthcare ETF (IXJ) provides investors with access to a diversified portfolio of global healthcare companies. The ETF's competitive advantage lies in its broad diversification, allowing investors to benefit from the stability and growth potential of the healthcare sector without having to focus on individual companies.

The ETF has a relatively low expense ratio of 0.43%, making it cost-effective compared to actively managed funds. This is particularly beneficial in a sector characterized by long-term growth opportunities, such as healthcare.

Another advantage is its global focus, allowing the fund to benefit from international market opportunities and diversify risk. This diversification and low costs make the IXJ an attractive option for investors looking to invest in the healthcare sector.

Institutional Investor Share: approx. 85% (estimated for 2025)

Insider Buys/Sells: No significant insider transactions reported (estimated for 2025)

The iShares Global Healthcare ETF (IXJ) is a popular ETF that is heavily demanded by institutional investors. The institutional investor share typically ranges from about 80-90%, indicating the interest of large funds and asset managers looking to invest in the global healthcare sector.

Insider buys or sells are less relevant for ETFs like IXJ, as it is a fund and not a single company. Therefore, there are no typical insider transactions as seen with individual stocks.

Market share of iShares Global Healthcare ETF (IXJ): Estimated around 5% in the global healthcare ETF segment (2025).

Top competitors and their market shares:

1. Vanguard Health Care ETF (VHT): around 10%
2. Health Care Select Sector SPDR Fund (XLV): around 9%
3. iShares U.S. Healthcare ETF (IYH): around 7%
4. Fidelity MSCI Health Care Index ETF (FHLC): around 6%
5. SPDR S&P Health Care Equipment ETF (XHE): around 4%

The iShares Global Healthcare ETF (IXJ) has a moderate market share compared to its competitors. The ETF offers broad diversification in the global healthcare sector, which provides a certain moat as it gives investors access to international healthcare companies not included in purely US-focused ETFs.

However, some of the competitors, especially the Vanguard Health Care ETF and the Health Care Select Sector SPDR Fund, have a stronger moat due to their size and focus on the US market. These ETFs benefit from high liquidity and a strong position in the world's largest healthcare market.

In summary, the iShares Global Healthcare ETF offers an advantage through its international diversification, but compared to the leading US-centric ETFs, it has a weaker moat.

Healthcare Sector Growth: 6.5% CAGR (2023-2028, forecast) Demographic Change: Increase in the older population worldwide Innovations in Healthcare: Rising investments in biotechnology and digital health

The iShares Global Healthcare ETF (ARCA:IXJ) provides investors with access to a diversified portfolio of companies in the healthcare sector, which is considered one of the most stable and fastest-growing sectors. The sector benefits from an aging population and an increasing demand for healthcare services and technologies.

Long-term, the healthcare sector is expected to grow at an average annual growth rate of around 6.5%, supported by innovations in biotechnology, personalized medicine, and digital health solutions. These factors could make the ETF an attractive investment, especially for investors interested in long-term growth.

Additionally, ETFs like IXJ offer diversification, which reduces risk compared to investing in individual stocks. Given these factors, the iShares Global Healthcare ETF could be a good investment opportunity for investors looking to benefit from long-term growth trends in the healthcare sector.

Dividend Yield: 1.5% (estimated for 2025)
Payout Frequency: Quarterly

The iShares Global Healthcare ETF (IXJ) regularly pays out dividends. The distributions typically occur quarterly, which is common for ETFs in the healthcare sector. The estimated dividend yield is around 1.5%, based on historical data and current market conditions.

The reliability of dividend payments is high, as the ETF invests in a variety of stable and established healthcare companies known for their consistent dividend payments. This provides investors with a certain level of security regarding the continuity of the payouts.